Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
- The FDA has approved MediWound Ltd's (NASDAQ:MDWD) NexoBrid (anacaulase-bcdb) to remove eschar in adults with deep partial-thickness and/or full-thickness thermal burns.
- NexoBrid, a botanical drug product containing proteolytic enzymes, is already approved in 43 countries.
- Recently, MediWound signed an agreement with Triskel Integrated Services to market and distribute NexoBrid in Switzerland, with a launch planned for Q1 of 2023. Triskel also holds the distribution rights of NexoBrid in France, where NexoBrid is expected to launch in Q3 2023.
- Vericel Corporation (NASDAQ:VCEL) holds an exclusive license to commercialize NexoBrid in North America.
- MediWound will receive a $7.5 million milestone payment from Vericel, triggered by the FDA approval of NexoBrid.
- NexoBrid can be applied in up to two applications of four hours each. The first application of NexoBrid may be applied to an area of up to 15% body surface area. The second application of NexoBrid may be applied 24 hours later, with a total treated area for both applications of up to 20% TBSA.
- In addition, BARDA has supported the evaluation of NexoBrid in the pediatric population, and the marketing application is expected to be submitted for FDA approval in 2023.
- Price Action: MDWD shares closed higher by 3.96% at $13.38 on Thursday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!